Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
110.77
Dollar change
+1.95
Percentage change
1.79
%
Index- P/E35.92 EPS (ttm)3.08 Insider Own0.03% Shs Outstand3.34B Perf Week3.72%
Market Cap369.80B Forward P/E27.32 EPS next Y4.05 Insider Trans0.00% Shs Float3.34B Perf Month5.13%
Income13.78B PEG3.27 EPS next Q0.89 Inst Own10.00% Short Float0.15% Perf Quarter-16.03%
Sales39.33B P/S9.40 EPS this Y20.11% Inst Trans-0.46% Short Ratio0.99 Perf Half Y-22.47%
Book/sh5.40 P/B20.49 EPS next Y24.40% ROA26.99% Short Interest4.93M Perf Year13.51%
Cash/sh3.36 P/C32.99 EPS next 5Y11.00% ROE88.20% 52W Range94.73 - 148.15 Perf YTD7.08%
Dividend Est.1.57 (1.42%) P/FCF32.63 EPS past 5Y16.48% ROI53.52% 52W High-25.23% Beta0.41
Dividend TTM1.45 (1.31%) Quick Ratio0.75 Sales past 5Y14.25% Gross Margin84.66% 52W Low16.93% ATR (14)2.43
Dividend Ex-DateAug 16, 2024 Current Ratio0.94 EPS Y/Y TTM28.07% Oper. Margin43.87% RSI (14)55.96 Volatility1.29% 1.68%
Employees63370 Debt/Eq0.47 Sales Y/Y TTM27.73% Profit Margin35.03% Recom1.91 Target Price140.93
Option/ShortYes / Yes LT Debt/Eq0.43 EPS Q/Q23.30% Payout36.03% Rel Volume1.21 Prev Close108.82
Sales Surprise-2.85% EPS Surprise0.19% Sales Q/Q22.49% EarningsNov 06 BMO Avg Volume4.98M Price110.77
SMA204.36% SMA50-0.74% SMA200-12.92% Trades Volume6,043,664 Change1.79%
Date Action Analyst Rating Change Price Target Change
May-30-24Initiated Goldman Buy $156
Apr-12-24Initiated BMO Capital Markets Outperform $163
Jan-23-24Initiated Morgan Stanley Overweight $120
Jan-16-24Resumed UBS Neutral
Dec-01-23Initiated Cantor Fitzgerald Overweight $120
Oct-02-23Initiated Argus Buy $110
Jul-14-23Initiated HSBC Securities Buy
Jul-15-22Upgrade Morgan Stanley Equal-Weight → Overweight
Jun-28-22Downgrade UBS Neutral → Sell
Jun-27-22Upgrade Exane BNP Paribas Underperform → Neutral
Today 06:46AM
03:15AM
Dec-06-24 01:11PM
01:04PM
Dec-05-24 05:45PM
09:00AM Loading…
09:00AM
08:30AM
08:00AM
07:20AM
Dec-04-24 04:20PM
04:02PM
01:40PM
01:05PM
11:59AM
11:42AM
11:15AM Loading…
11:15AM
10:21AM
09:41AM
08:16AM
07:16AM
07:10AM
06:07AM
03:03AM
Dec-03-24 06:24PM
08:00AM
06:00AM
Dec-02-24 01:22PM
12:46PM
07:47AM
06:46AM
02:42PM Loading…
Dec-01-24 02:42PM
Nov-30-24 02:42PM
Nov-29-24 05:35AM
Nov-28-24 07:33AM
Nov-27-24 12:17PM
01:39AM
Nov-26-24 05:16PM
02:23PM
01:49PM
01:28PM
01:04PM
12:44PM
12:33PM
12:03PM
11:31AM
09:54AM
09:16AM
08:54AM
07:21AM
Nov-25-24 02:51PM
02:51PM
02:38PM
10:16AM
09:19AM
Nov-23-24 10:21AM
Nov-22-24 04:17PM
11:49AM
11:00AM
09:34AM
09:08AM
08:00AM
05:00AM
05:00AM
Nov-21-24 02:00AM
Nov-20-24 11:14AM
06:10AM
03:30AM
Nov-19-24 08:33AM
07:47AM
05:30AM
05:30AM
Nov-18-24 05:49PM
01:27PM
10:08AM
06:03AM
06:02AM
12:44AM
Nov-16-24 09:00AM
Nov-15-24 12:04PM
09:34AM
09:13AM
06:45AM
Nov-14-24 07:15AM
Nov-13-24 04:06PM
12:42PM
11:18AM
09:49AM
09:48AM
09:48AM
Nov-12-24 04:44PM
04:38PM
02:00PM
09:45AM
Nov-11-24 12:20PM
Nov-10-24 05:45AM
05:15AM
Nov-09-24 09:00AM
Nov-08-24 04:22PM
03:51PM
03:47PM
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.